These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 15478581)
21. [Survival analysis and prognosis of lung cancer related factors]. Fan ZM; Shu ZG; Tan JP Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):674-5. PubMed ID: 21882475 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike. Barton MK CA Cancer J Clin; 2012; 62(5):279-80. PubMed ID: 22847502 [No Abstract] [Full Text] [Related]
23. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma]. Wolf M Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685 [TBL] [Abstract][Full Text] [Related]
24. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A]. Mornex F Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239 [No Abstract] [Full Text] [Related]
25. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)]. Papadakis E Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238 [No Abstract] [Full Text] [Related]
26. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer]. Yu DP; Bai LQ; Xu SF; Han M; Wang ZT Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561 [TBL] [Abstract][Full Text] [Related]
27. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ; J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657 [TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant therapy of stage III non-small cell lung cancer]. Hara N; Ohta M Kyobu Geka; 1991 Dec; 44(13):1114-20. PubMed ID: 1661792 [TBL] [Abstract][Full Text] [Related]
29. Treatment of lung cancer. Gadgeel SM; Ramalingam SS; Kalemkerian GP Radiol Clin North Am; 2012 Sep; 50(5):961-74. PubMed ID: 22974781 [TBL] [Abstract][Full Text] [Related]
30. The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials. Wheatley-Price P; Le MaƮtre A; Ding K; Leighl N; Hirsh V; Seymour L; Bezjak A; Shepherd FA; J Thorac Oncol; 2010 May; 5(5):640-8. PubMed ID: 20354457 [TBL] [Abstract][Full Text] [Related]
31. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H; J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093 [TBL] [Abstract][Full Text] [Related]
32. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
33. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G; Rusthoven J; Newman T; Findlay B; Evans W Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750 [TBL] [Abstract][Full Text] [Related]
34. Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist. Medford-Davis L; Decamp M; Recht A; Flickinger J; Belani CP; Varlotto J Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1048-57. PubMed ID: 22632771 [TBL] [Abstract][Full Text] [Related]
35. Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer. Daly BD; Ebright MI; Walkey AJ; Fernando HC; Zaner KS; Morelli DM; Kachnic LA J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1392-7. PubMed ID: 21281948 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients. Kim AW; Liptay MJ; Bonomi P; Warren WH; Basu S; Farlow EC; Faber LP Ann Thorac Surg; 2011 Jul; 92(1):233-41; discussion 241-3. PubMed ID: 21620372 [TBL] [Abstract][Full Text] [Related]
37. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients. Koumarianou A; Fountzilas G; Kosmidis P; Klouvas G; Samantas E; Kalofonos C; Pentheroudakis G; Economopoulos T; Pectasides D J Chemother; 2009 Nov; 21(5):573-83. PubMed ID: 19933050 [TBL] [Abstract][Full Text] [Related]
38. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer. Davidoff AJ; Gardner JF; Seal B; Edelman MJ J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743 [TBL] [Abstract][Full Text] [Related]